Serum anti-PLA2R negativity does not exclude glomerular PLA2R expression in primary membranous nephropathy
Şenay Yıldırim, Ayça İnci, Ayşe Karaduru Avcı, Lütfullah Zahit Koç, Döndü Nergiz, Üstün Yılmaz · 2026
Read Serum anti-PLA2R negativity does not exclude glomerular PLA2R expression in primary membranous nephropathy by Şenay Yıldırim, Ayça İnci, Ayşe Karaduru Avcı, Lütfullah Zahit Koç, Döndü Nergiz, Üstün Yılmaz (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13394611.txt.
Description
Yıldırim and colleagues investigate, in 2026, a diagnostic puzzle in primary membranous nephropathy, a kidney disease that is a leading cause of nephrotic syndrome in adults. Blood tests for antibodies against the PLA2R antigen now guide care, but doctors debate how blood results relate to antigen deposits in the kidney. The team reviewed 49 biopsy-confirmed patients from 2018 to 2025, comparing serum antibody levels with PLA2R staining in kidney tissue.
The mismatch was striking: only 49.0 percent of patients had positive blood antibody tests, yet every biopsy, 100 percent of the cohort, showed PLA2R expression in the glomeruli. That included all patients whose blood tests came back negative before biopsy. Tissue staining intensity was graded from zero to strongly positive, giving seronegative patients a route that blood work missed. The authors conclude a negative serum result should not rule out PLA2R disease when biopsy staining is available.
Catalog record
| CREATOR | Şenay Yıldırim, Ayça İnci, Ayşe Karaduru Avcı, Lütfullah Zahit Koç, Döndü Nergiz, Üstün Yılmaz |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |